Blockbuster Weight-Loss Drug Linked to Serious Kidney Issues

a man holding his stomach with his hands

Joseph Mercola Semaglutide, the blockbuster drug being used for weight loss, is slated to bring in more than $10 billion in annual sales but serious adverse e!ects are emerging. A study using data from Eudravigilance, Europe’s system for analyzing adverse reactions to medications, found a high prevalence of gastrointestinal disorders among users. Other semaglutide patients […]